MAZE
Maze Therapeutics, Inc.
$31.99
-0.85 (-2.59%)
At close · Jul 8
Market Cap
$1.79B
Shares
55,345,261
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-10 | 2026-06-08 | |
| 8-K | 2026-05-22 | 2026-05-18 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| DEF 14A | 2026-04-28 | 2026-06-08 | |
| 8-K | 2026-04-22 | 2026-04-21 | |
| 10-K | 2026-03-25 | 2025-12-31 | |
| 8-K | 2026-03-25 | 2026-03-24 | |
| 8-K | 2026-02-04 | 2026-02-02 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-06 | — | |
| 8-K | 2025-09-11 | 2025-09-10 | |
| 8-K | 2025-09-02 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-31 | — |
Showing 1–22 of 22 filings